Dr Reddy's inks pact with Johnson & Johnson to acquire vertigo treatment brand

Core Insights - Dr. Reddy's Laboratories has completed the acquisition of the Stugeron brand from Johnson & Johnson, which includes markets in EMEA, India, and Vietnam [1] - This acquisition enables Dr. Reddy's to enhance its presence in the anti-vertigo market and strengthen its Central Nervous System portfolio [1] - The company plans to expand Stugeron's availability across 18 key markets, aligning with its strategic growth objectives [1]